MX2009001351A - Compuestos bioactivos multifuncionales. - Google Patents
Compuestos bioactivos multifuncionales.Info
- Publication number
- MX2009001351A MX2009001351A MX2009001351A MX2009001351A MX2009001351A MX 2009001351 A MX2009001351 A MX 2009001351A MX 2009001351 A MX2009001351 A MX 2009001351A MX 2009001351 A MX2009001351 A MX 2009001351A MX 2009001351 A MX2009001351 A MX 2009001351A
- Authority
- MX
- Mexico
- Prior art keywords
- bioactive compounds
- multifunctional bioactive
- immune
- disorders
- multifunctional
- Prior art date
Links
- 230000000975 bioactive effect Effects 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 208000031422 Lymphocytic Chronic B-Cell Leukemia Diseases 0.000 abstract 1
- 208000034578 Multiple myelomas Diseases 0.000 abstract 1
- 208000015914 Non-Hodgkin lymphomas Diseases 0.000 abstract 1
- 206010035226 Plasma cell myeloma Diseases 0.000 abstract 1
- 230000001684 chronic effect Effects 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000002607 hemopoietic effect Effects 0.000 abstract 1
- 208000026278 immune system disease Diseases 0.000 abstract 1
- 230000004957 immunoregulator effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000003381 stabilizer Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
- C07H5/04—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen
- C07H5/06—Aminosugars
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0215—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/50—Cyclic peptides containing at least one abnormal peptide link
- C07K7/52—Cyclic peptides containing at least one abnormal peptide link with only normal peptide links in the ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Transplantation (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US83542806P | 2006-08-04 | 2006-08-04 | |
| PCT/CA2007/001357 WO2008014613A1 (en) | 2006-08-04 | 2007-08-01 | Multifunctional bioactive compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2009001351A true MX2009001351A (es) | 2009-05-11 |
Family
ID=38996830
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2009001351A MX2009001351A (es) | 2006-08-04 | 2007-08-01 | Compuestos bioactivos multifuncionales. |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US8637521B2 (enExample) |
| EP (1) | EP2046778B1 (enExample) |
| JP (1) | JP5357022B2 (enExample) |
| CN (1) | CN101511823B (enExample) |
| AU (1) | AU2007280995C1 (enExample) |
| BR (1) | BRPI0714616A2 (enExample) |
| CA (1) | CA2659875C (enExample) |
| EA (1) | EA018548B1 (enExample) |
| MX (1) | MX2009001351A (enExample) |
| WO (1) | WO2008014613A1 (enExample) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9006175B2 (en) | 1999-06-29 | 2015-04-14 | Mannkind Corporation | Potentiation of glucose elimination |
| ATE385193T1 (de) | 2002-03-20 | 2008-02-15 | Mannkind Corp | Inhalationsgerät |
| DK1786784T3 (da) | 2004-08-20 | 2011-02-14 | Mannkind Corp | Katalyse af diketopiperazinsyntese |
| BRPI0514293B1 (pt) | 2004-08-23 | 2022-07-19 | Mannkind Corporation | Sistema microparticulado para distribuição de droga |
| DK1928423T3 (en) | 2005-09-14 | 2016-02-29 | Mannkind Corp | A method for drug formulation based on increasing the affinity of the active substances to the crystalline microparticle surfaces |
| CA2643464C (en) | 2006-02-22 | 2018-09-04 | Mannkind Corporation | A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent |
| CA2571645A1 (en) * | 2006-12-19 | 2008-06-19 | Apotex Technologies Inc. | Pharmaceutically acceptable salts of thymodepressin and processes for their manufacture |
| WO2011163272A1 (en) | 2010-06-21 | 2011-12-29 | Mannkind Corporation | Dry powder drug delivery system and methods |
| US8485180B2 (en) | 2008-06-13 | 2013-07-16 | Mannkind Corporation | Dry powder drug delivery system |
| CN106039494B (zh) | 2008-06-13 | 2019-12-24 | 曼金德公司 | 干粉吸入器和用于药物输送的系统 |
| BRPI0914308B8 (pt) | 2008-06-20 | 2021-06-22 | Mannkind Corp | sistema de inalação |
| TWI614024B (zh) | 2008-08-11 | 2018-02-11 | 曼凱公司 | 超快起作用胰島素之用途 |
| US8314106B2 (en) | 2008-12-29 | 2012-11-20 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
| CA2748490C (en) * | 2008-12-29 | 2016-10-04 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
| CA2749163A1 (en) | 2009-01-14 | 2010-07-22 | The Salk Institute For Biological Studies | Methods for screening and compounds that protect against amyloid diseases |
| WO2010105094A1 (en) | 2009-03-11 | 2010-09-16 | Mannkind Corporation | Apparatus, system and method for measuring resistance of an inhaler |
| MY186975A (en) | 2009-06-12 | 2021-08-26 | Mannkind Corp | Diketopiperazine microparticles with defined specific surface areas |
| AU2010282169A1 (en) | 2009-08-10 | 2012-03-08 | Immunotech Developments Inc. | Vaccine having a peptide adjuvant for eliciting a specific immune response to treat viral infection and other conditions |
| EP2496295A1 (en) | 2009-11-03 | 2012-09-12 | MannKind Corporation | An apparatus and method for simulating inhalation efforts |
| MY180552A (en) | 2011-04-01 | 2020-12-02 | Mannkind Corp | Blister package for pharmaceutical cartridges |
| WO2012174472A1 (en) | 2011-06-17 | 2012-12-20 | Mannkind Corporation | High capacity diketopiperazine microparticles |
| JP6018640B2 (ja) | 2011-10-24 | 2016-11-02 | マンカインド コーポレイション | 疼痛を緩和するのに有効な鎮痛組成物並びに当該組成物を含む乾燥粉末及び乾燥粉末薬剤輸送システム |
| PL2812372T3 (pl) | 2012-02-09 | 2018-12-31 | Novus International Inc. | Cykliczne dimery zawierające heteroatom |
| WO2013166110A1 (en) * | 2012-05-02 | 2013-11-07 | Yale University | Tlr-agonist-conjugated antibody recruiting molecules (tlr_arms) |
| DK2872205T3 (en) | 2012-07-12 | 2017-02-27 | Mannkind Corp | DRY POWDER FORMAL ADMINISTRATION SYSTEM |
| WO2014011857A1 (en) | 2012-07-12 | 2014-01-16 | Novus International Inc. | Matrix and layer compositions for protection of bioactives |
| WO2014016787A2 (en) | 2012-07-24 | 2014-01-30 | Pharma Bio Llc | Peptide-based compounds and uses thereof to treat beta-amyloid accumulation |
| WO2014066856A1 (en) | 2012-10-26 | 2014-05-01 | Mannkind Corporation | Inhalable influenza vaccine compositions and methods |
| KR102391750B1 (ko) | 2013-03-15 | 2022-04-28 | 맨카인드 코포레이션 | 미세결정성 디케토피페라진 조성물 및 방법 |
| EP3021834A1 (en) | 2013-07-18 | 2016-05-25 | MannKind Corporation | Heat-stable dry powder pharmaceutical compositions and methods |
| US11446127B2 (en) | 2013-08-05 | 2022-09-20 | Mannkind Corporation | Insufflation apparatus and methods |
| WO2015148905A1 (en) | 2014-03-28 | 2015-10-01 | Mannkind Corporation | Use of ultrarapid acting insulin |
| US10561806B2 (en) | 2014-10-02 | 2020-02-18 | Mannkind Corporation | Mouthpiece cover for an inhaler |
| US10584306B2 (en) | 2017-08-11 | 2020-03-10 | Board Of Regents Of The University Of Oklahoma | Surfactant microemulsions |
| CN110054619A (zh) * | 2018-01-18 | 2019-07-26 | 西北农林科技大学 | 新型二酮哌嗪类组蛋白去乙酰化酶抑制剂 |
| WO2020041965A1 (en) * | 2018-08-28 | 2020-03-05 | Lingdong Technology (Beijing) Co., Ltd | Self-driving systems with inventory holder |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4006261A (en) * | 1973-09-28 | 1977-02-01 | Firmenich S.A. | Flavoring with mixtures of theobromine and cyclic dipeptides |
| US4289759A (en) * | 1980-06-23 | 1981-09-15 | Ortho Pharmaceutical Corporation | Immunoregulatory diketopiperazine compounds |
| US4331595A (en) * | 1980-06-23 | 1982-05-25 | Ortho Pharmaceutical Corporation | Immunoregulatory diketopiperazine compounds |
| GB8427735D0 (en) * | 1984-11-02 | 1984-12-12 | Fujisawa Pharmaceutical Co | Piperazine compound |
| DE3909379A1 (de) * | 1989-03-22 | 1990-09-27 | Cassella Ag | Thienylpiperazine, verfahren zu ihrer herstellung, ihre verwendung sowie diese enthaltende arzneimittel und deren herstellung |
| US6331318B1 (en) | 1994-09-30 | 2001-12-18 | Emisphere Technologies Inc. | Carbon-substituted diketopiperazine delivery systems |
| US5693338A (en) * | 1994-09-29 | 1997-12-02 | Emisphere Technologies, Inc. | Diketopiperazine-based delivery systems |
| FR2677361A1 (fr) | 1991-06-04 | 1992-12-11 | Adir | Nouveaux peptides et pseudopeptides, derives de tachykinines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| ATE188219T1 (de) * | 1991-10-28 | 2000-01-15 | Cytran Ltd | Pharmazeutische dipeptid zusammensetzungen und verwendungsmethoden. |
| US5352461A (en) * | 1992-03-11 | 1994-10-04 | Pharmaceutical Discovery Corporation | Self assembling diketopiperazine drug delivery system |
| FR2722787B1 (fr) * | 1994-07-21 | 1996-10-11 | Univ Claude Bernard Lyon | Composes a activite anthelminthique: dicetopiperazines, precurseurs et analogues |
| US6103699A (en) | 1996-06-07 | 2000-08-15 | Immunotech Developments Inc. | Peptide, a method for its preparation and a pharmaceutical composition containing the peptide |
| US6060452A (en) * | 1996-03-13 | 2000-05-09 | Cytran, Inc. | Analogs of L-Glu-L-Trp having pharmacological activity |
| US5932579A (en) * | 1996-06-18 | 1999-08-03 | Affymax Technologies N.V. | Collagenase-1 and stromelysin-1 inhibitors, pharmaceutical compositions comprising same and methods of their use |
| JPH10226615A (ja) * | 1997-02-18 | 1998-08-25 | Pola Chem Ind Inc | アスパラギン酸フェニルアラニン環状ジペプタイド誘導体を含有する組成物 |
| US7026322B2 (en) | 1998-11-12 | 2006-04-11 | Nereus Pharmaceuticals, Inc. | Phenylahistin and the phenylahistin analogs, a new class of anti-tumor compounds |
| DE19937721A1 (de) * | 1999-08-10 | 2001-02-15 | Max Planck Gesellschaft | Neue Diketopiperazine |
| US6974478B2 (en) | 1999-10-22 | 2005-12-13 | Archus Orthopedics, Inc. | Prostheses, systems and methods for replacement of natural facet joints with artificial facet joint surfaces |
| JP2001247566A (ja) * | 2000-03-03 | 2001-09-11 | Marine Biotechnol Inst Co Ltd | 新規抗カビ活性物質およびその製造法 |
| PT1311269E (pt) * | 2000-08-04 | 2012-05-10 | Dmi Biosciences Inc | Método de utilização de dicetopiperazinas e composição que contém as mesmas |
| US20030171379A1 (en) * | 2001-12-28 | 2003-09-11 | Jacobs Robert S. | Methods of treating, preventing, or inhibiting inflammation with Mactanamide compounds |
| JP3846409B2 (ja) | 2002-02-15 | 2006-11-15 | 株式会社村田製作所 | 弾性表面波装置、通信装置 |
| KR20120101164A (ko) | 2003-05-15 | 2012-09-12 | 디엠아이 바이오사이언시스, 인크 | Ｔ-세포 매개성 질환의 치료 방법 |
| BRPI0514293B1 (pt) * | 2004-08-23 | 2022-07-19 | Mannkind Corporation | Sistema microparticulado para distribuição de droga |
-
2007
- 2007-08-01 MX MX2009001351A patent/MX2009001351A/es active IP Right Grant
- 2007-08-01 BR BRPI0714616-7A2A patent/BRPI0714616A2/pt not_active Application Discontinuation
- 2007-08-01 CN CN200780033302.7A patent/CN101511823B/zh not_active Expired - Fee Related
- 2007-08-01 CA CA 2659875 patent/CA2659875C/en active Active
- 2007-08-01 JP JP2009522067A patent/JP5357022B2/ja not_active Expired - Fee Related
- 2007-08-01 EP EP07785022.0A patent/EP2046778B1/en active Active
- 2007-08-01 WO PCT/CA2007/001357 patent/WO2008014613A1/en not_active Ceased
- 2007-08-01 EA EA200970178A patent/EA018548B1/ru not_active IP Right Cessation
- 2007-08-01 AU AU2007280995A patent/AU2007280995C1/en not_active Ceased
- 2007-08-01 US US12/376,138 patent/US8637521B2/en active Active
-
2013
- 2013-12-19 US US14/134,418 patent/US9108931B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2046778B1 (en) | 2013-12-04 |
| CN101511823A (zh) | 2009-08-19 |
| EA018548B1 (ru) | 2013-08-30 |
| JP2009545534A (ja) | 2009-12-24 |
| AU2007280995A1 (en) | 2008-02-07 |
| CA2659875C (en) | 2015-01-27 |
| WO2008014613A1 (en) | 2008-02-07 |
| US9108931B2 (en) | 2015-08-18 |
| CA2659875A1 (en) | 2008-02-07 |
| US20140179708A1 (en) | 2014-06-26 |
| EP2046778A1 (en) | 2009-04-15 |
| BRPI0714616A2 (pt) | 2013-06-11 |
| JP5357022B2 (ja) | 2013-12-04 |
| CN101511823B (zh) | 2014-07-30 |
| EA200970178A1 (ru) | 2009-08-28 |
| AU2007280995C1 (en) | 2013-05-23 |
| AU2007280995B2 (en) | 2012-05-03 |
| HK1124608A1 (en) | 2009-07-17 |
| EP2046778A4 (en) | 2010-09-08 |
| US8637521B2 (en) | 2014-01-28 |
| US20100048586A1 (en) | 2010-02-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2009001351A (es) | Compuestos bioactivos multifuncionales. | |
| MX2010005136A (es) | Prevencion y tratamiento de infecciones secundarias tras una infeccion viral. | |
| SG145693A1 (en) | Amino acid prodrugs | |
| MX2011012366A (es) | Mezclas fungicidas sinergeticas. | |
| GEP20146125B (en) | Aminopyrimidines as syk inhibitors | |
| EA201070238A1 (ru) | Соединения пиримидина | |
| PH12013500913A1 (en) | Substituted-quinoxaline-type-piperidine compounds and the uses thereof | |
| WO2010142766A3 (en) | Pyrimidine derivatives as zap-70 inhibitors | |
| WO2010057101A3 (en) | Compounds useful as hiv blockers | |
| MY158974A (en) | Prodrugs comprising an exendin linker conjugate | |
| WO2008064018A8 (en) | Thienopyrimidinones for treatment of inflammatory disorders and cancers | |
| WO2009147205A3 (en) | Synergistic fungicidal mixtures | |
| WO2007070598A3 (en) | Nucleotide and oligonucleotide prodrugs | |
| TN2012000011A1 (en) | Prodrugs comprising an insulin linker conjugate | |
| MX2010009561A (es) | Compuestos amida, composiciones y usos de los mismos. | |
| UA104010C2 (en) | Purine compounds | |
| TNSN08444A1 (en) | Bicyclic derivatives as cetp inhibitors | |
| WO2008061724A3 (en) | Compositions comprising carnosic acid 12-methylether | |
| GB0625648D0 (en) | Compounds | |
| TW200639141A (en) | CXCR2 inhibitors | |
| TW200719890A (en) | Bicyclic [3. 1. 0] heteroaryl amides as type i glycine transport inhibitors | |
| MX2010003002A (es) | Analogos de azacitidina y sus usos. | |
| UA103181C2 (ru) | Соединения, которые ингибируют дипептидилпептидазу-iv и фармацевтическая композиция, которая содержит их как активный агент | |
| TN2011000172A1 (en) | Therapeutic antiviral peptides | |
| TW200806300A (en) | New therapeutic combinations for the treatment of depression |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HH | Correction or change in general | ||
| FG | Grant or registration |